News

FDA mandates new opioid labeling to highlight long-term risks, aiming to combat addiction and improve patient safety in pain ...
The U.S. Food and Drug Administration is requiring major safety labeling changes for all opioid pain medications, warning about addiction, overdose and long-term risks.
A new drug dubbed ā€˜flysky’ is spreading through the US, with officials warning it can kill. The drug is being sold throughout ...
"The latest expansion of the program is at the Blue Springs Chamber of Commerce on Main Street, where Jackson County Public ...
Kratom manufacturers caution that the supplement isn't always safe in the unregulated market. Lawmakers are now seeking to ...
As President Trump's August 1st trade deal deadline arrives, a new trade landscape emerges with the U.S. imposing higher tariffs on Canadian imports and extending negotiations with Mexico.
Cambodian Defense Ministry Spokesperson Maly Socheata confirmed that the two wounded soldiers had been handed over at a ...
The U.S. Food and Drug Administration is taking significant steps in the ongoing fight against the Opioid Crisis.
The FDA is requiring safety labeling changes to all opioid painkillers, to better highlight the risks posed by using the ...
The FDA is recommending that certain products containing 7-hydroxymitragynine be subject to the Controlled Substances Act.
The Food and Drug Administration (FDA) is requiring class-wide label changes for opioid medications to provide additional information on the risks associated with long-term use.